
pmid: 22117874
Nonmelanoma skin cancers (NMSCs) represent the most common cancer in the United States, accounting for more than 2 million cases per year. Despite the magnitude of health burden on the US population, there remain many questions regarding the epidemiology, health outcomes, and treatments of NMSCs. This article highlights these areas of clinical and research need. The article focuses on the recent epidemiologic trends as well as health outcomes of NMSCs in the United States. In addition, current national guidelines, available treatments and care pathways, and clinical trials are discussed.
Skin Neoplasms, Carcinoma, Basal Cell, Incidence, Outcome Assessment, Health Care, Carcinoma, Squamous Cell, Humans, Dermatology, United States
Skin Neoplasms, Carcinoma, Basal Cell, Incidence, Outcome Assessment, Health Care, Carcinoma, Squamous Cell, Humans, Dermatology, United States
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 85 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
